Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. Univ. Heart J. [Internet]. 2022 Jan. 31 [cited 2026 Jul. 1];18(1):10-3. Available from: https://www.banglajol.info/index.php/UHJ/article/view/57874